We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.27B
AUM Growth
–
Cap. Flow
+$2.08B
Cap. Flow %
91.71%
Top 10 Hldgs %
60.91%
Holding
226
New
226
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$220M
2
MXIM
Maxim Integrated Products
MXIM
+$217M
3
XLNX
Xilinx Inc
XLNX
+$177M
4
NUAN
Nuance Communications, Inc.
NUAN
+$119M
5
WORK
Slack Technologies, Inc.
WORK
+$108M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Healthcare 18.72%
3 Financials 17.48%
4 Consumer Discretionary 8.17%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFAQ
176
DELISTED
AF Acquisition Corp
AFAQ
$904K 0.04%
+92,647
New +$902K
GCAC
177
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
$871K 0.04%
+89,793
New +$874K
SDAC
178
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$859K 0.04%
+88,541
New +$865K
BLUA
179
DELISTED
BlueRiver Acquisition Corp.
BLUA
$832K 0.04%
+85,723
New +$836K
UHG
180
DELISTED
United Homes Group
UHG
$810K 0.04%
+83,471
New +$814K
HPX
181
DELISTED
HPX Corp.
HPX
$801K 0.04%
+81,361
New +$800K
RBOT
182
DELISTED
Vicarious Surgical
RBOT
$794K 0.04%
+2,655
New +$791K
SLAC
183
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$764K 0.03%
+78,622
New +$767K
ADER
184
DELISTED
26 Capital Acquisition Corp
ADER
$744K 0.03%
+76,658
New +$747K
VHAQ
185
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$743K 0.03%
+75,090
New +$744K
ISLE
186
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$725K 0.03%
+73,952
New +$722K
HCII
187
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$719K 0.03%
+74,092
New +$728K
IBER
188
DELISTED
Ibere Pharmaceuticals
IBER
$717K 0.03%
+74,143
New +$721K
RUM icon
189
RUM Group Inc
RUM
$1.56B
$696K 0.03%
+71,449
New +$698K
TMAC
190
DELISTED
The Music Acquisition Corporation
TMAC
$691K 0.03%
+71,490
New +$699K
TOI icon
191
The Oncology Institute
TOI
$477M
$688K 0.03%
+69,099
New +$696K
BNZI icon
192
Banzai International
BNZI
$5.8M
$684K 0.03%
+7
New +$686K
PRST
193
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$678K 0.03%
+68,324
New +$680K
OACB
194
DELISTED
Oaktree Acquisition Corp. II
OACB
$663K 0.03%
+67,101
New +$665K
SNRH
195
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$662K 0.03%
+68,061
New +$667K
CPUH
196
DELISTED
Compute Health Acquisition Corp.
CPUH
$621K 0.03%
+63,195
New +$620K
LEGOW
197
DELISTED
Legato Merger Corp. Warrant
LEGOW
$596K 0.03%
+322,968
New +$311K
QDRO
198
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$536K 0.02%
+55,515
New +$540K
ACII
199
DELISTED
Atlas Crest Investment Corp. II
ACII
$527K 0.02%
+54,043
New +$532K
ASPCU
200
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
$523K 0.02%
+53,899
New +$540K
6 7
8
9 10

Similar funds

XEA
XN Exponent Advisors New York $2.09B AUM 32.83% 1-Year Est. Return
AIC
Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return
QAM
QCI Asset Management Pittsford, New York $1.72B AUM 25.41% 1-Year Est. Return
BU
BBVA USA Birmingham, Alabama $1.71B AUM
H
Hexavest Montreal, Quebec, Canada $1.64B AUM 28.34% 1-Year Est. Return
FMW
Farr Miller & Washington Washington, District of Columbia $1.53B AUM 32.74% 1-Year Est. Return
MAFM
Mid Atlantic Financial Management Pittsburgh, Pennsylvania $1.49B AUM 24.08% 1-Year Est. Return
BOS
Bingham Osborn & Scarborough San Francisco, California $1.42B AUM 27.88% 1-Year Est. Return

Omni Partners US's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for Omni Partners US, which disclosed 226 positions worth $2.27B. Its ten largest holdings account for 61% of the portfolio.

Its largest position is Alexion Pharmaceuticals: 1,283,115 shares worth $326M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, followed by Healthcare and Financials.

  • Omni Partners US's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,283,115 shares worth $326M.
  • Omni Partners US's ten largest holdings make up 61% of its $2.27B portfolio in Q2 2021.
  • Omni Partners US disclosed 226 positions in Q2 2021, its first 13F filing on record.

Based on Omni Partners US's 13F filing for Q2 2021, filed 16 Aug 2021.